Literature DB >> 10871249

The management of multiple sclerosis patients.

M G Clanet1, D Brassat.   

Abstract

The management of individuals with multiple sclerosis must be considered under the following headings: administration and follow-up of adequate disease-modifying treatment, symptomatic relief and neurorehabilitation. Neurorehabilitation deserves a four-step strategy: multidisciplinary assessment, identification of areas of potential functional improvement, setting of goals of short/long-term duration, and measurement of outcomes. The patient's perspective is important to evaluate through questionnaires about quality of life. Well organized disability services with multidisciplinary specialists are probably cost effective and efficient. Determining the actual economic impact of multiple sclerosis and defining the most cost-effective type of care for persons with multiple sclerosis is a need in all countries faced with the limitation of healthcare resources. In persons with multiple sclerosis the range of main symptoms includes the loss of mobility and spasticity, pain, tremor, abnormal eye movements, paroxysmal symptoms, bladder and bowel dysfunction, sexual disturbances, fatigue and depression. Current palliative treatments, which are reviewed, are partly successful depending on the type of symptoms under consideration.

Entities:  

Mesh:

Year:  2000        PMID: 10871249     DOI: 10.1097/00019052-200006000-00005

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  5 in total

1.  [Deep brain stimulation for tremor in multiple sclerosis : consensus recommendations of the German Deep Brain Stimulation Association].

Authors:  L Timmermann; G Deuschl; W Fogel; R Hilker; A Kupsch; M Lange; C Schrader; F Sixel-Döring; J Volkmann; R Benecke
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

Review 2.  [Therapy of day time fatigue in patients with multiple sclerosis].

Authors:  Udo A Zifko
Journal:  Wien Med Wochenschr       Date:  2003

3.  Pain due to multiple sclerosis: analysis of the prevalence and economic burden in Canada.

Authors:  Charles Piwko; Olivier B Desjardins; Basil G Bereza; Marcio Machado; Barbara Jaszewski; Mark S Freedman; Thomas R Einarson; Michael Iskedjian
Journal:  Pain Res Manag       Date:  2007       Impact factor: 3.037

4.  Effects of low dose methotrexate on relapsing-remitting multiple sclerosis in comparison to Interferon β-1α: A randomized controlled trial.

Authors:  Fereshteh Ashtari; Mohammad Reza Savoj
Journal:  J Res Med Sci       Date:  2011-04       Impact factor: 1.852

5.  Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial.

Authors:  Vahid Shaygannejad; Mohsen Janghorbani; Fereshteh Ashtari; Hamed Dehghan
Journal:  Mult Scler Int       Date:  2012-04-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.